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Abstract
Vitreous humor is a potential alternative matrix for postmortem toxicology drug screens when
peripheral blood is unavailable. It is easily and reliably collected and may not suffer from the
same postmortem redistribution as seen in blood. Here, we compared the concentrations of 7
acidic drugs (acetaminophen, ibuprofen, naproxen, salicylic acid, carbamazepine, phenobarbital
and phenytoin) in peripheral blood and vitreous fluid collected in 89 autopsy cases. Analysis was
done by high-performance liquid chromatography with diode-array detection. Overall, we found
that vitreous drug concentrations were significantly lower than peripheral blood with median
vitreous to peripheral blood (V/PB) ratios ranging from 0.0 to 0.6 (mean, 0.1–0.6). The correlations
between the concentrations of over-the-counter analgesics in peripheral blood versus vitreous fluid
were poor, with acetaminophen exhibiting the best linearity (R2 = 0.72). The antiepileptic drugs
(carbamazepine, phenytoin and phenobarbital) exhibited good correlations between peripheral
blood and vitreous humor, with all exhibiting an R2 ≥ 0.95. Overall, we have demonstrated the
potential of vitreous fluid as an alternative matrix for the detection of select acidic drugs.
Introduction
Themost commonly used matrix in postmortem toxicology is periph-
eral blood. However, this matrix may suffer from changes in drug
concentrations due to postmortem redistribution (PMR) (1–5) mak-
ing it difficult to interpret. This redistribution of chemicals from
tissue (high concentration) to blood (low concentration) was first
described several decades ago (6, 7). Since then, several groups have
tried to estimate antemortem concentrations based on postmortem
values. Although none have yet to find a high degree of correlation
(8–10), a recent investigation has proposed a technique to estimate
potential for PMR (11). Cases of suspected overdose, homicidal
poisonings, suicides andmotor vehicle deaths are all highly dependent
on toxicology screens in peripheral blood. This matrix may not be
available in cases with massive blood loss. Furthermore, delayed
collection of blood after death may result in PMR, which may
complicate interpretation of quantitative drug concentrations (1).
Vitreous humor is a clear gelatinous substance that is routinely
collected from the eye during autopsy. It has been proposed as an
alternative matrix when peripheral blood or urine is not available
(12, 13). It is thought to be less susceptible to redistribution due
to its isolated nature (14); however, this has been debated (2).
Vitreous fluid is also protected from putrefaction, rarely suffers from
trauma and generally lacks microorganisms that may alter certain
drug concentration such as ethanol (2). Limitations of vitreous fluid
include small specimen volume and the variability of drug penetration
of the blood–retinal barrier (15). Several methods are being developed
to measure a variety of compounds in vitreous humor (13, 16–20),
but the relationship to peripheral blood is not well understood.
Previously, we compared drug concentrations between human
vitreous fluid and peripheral blood using a gas chromatography-mass
spectrometry (GC–MS) broad spectrum screen for 71 identified drugs
(21). In this study, we examined concentrations of a subset of acidic
drugs in these two matrices using high-performance liquid chro-
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matography with diode-array detection (HPLC-DAD). These include
the over-the-counter (OTC) analgesics, acetaminophen, ibuprofen,
naproxen and salicylic acid, as well as the antiepileptic drugs (AEDs),
carbamazepine, phenobarbital and phenytoin. We employed HPLC-
DAD to investigate the potential of vitreous humor as an alternative
matrix for postmortem analysis. Specifically, we compared concen-
trations of these seven acidic drugs in peripheral blood to vitreous
fluid and determined the correlations between the two matrices.
Experimental methods
Sample collection
Peripheral blood and vitreous humor samples from 89 autopsy
cases were collected during forensic autopsies. Peripheral blood was
collected from the common iliac vein after being visually identified in
the pelvis. Blood (up to 20 mL) was stored in glass tubes containing
sodium fluoride (100 mg) and potassium oxalate (20 mg). Vitreous
fluid was collected from both eyes using a syringe and was stored
in glass tubes without preservatives. All samples were stored at 4◦C
until analysis.
Materials and reagent preparation
OmniSolv grade acetonitrile was purchased from EMD Millipore
(Temecula, CA). Dibasic anhydrous potassium phosphate and
concentrated phosphoric acid were purchased from Fisher Scientific
(Pittsburg, PA). Drug standards were purchased from Alltech
(Hesperia, CA) and used to prepare calibrators at three different
concentrations by transferring stock standard solution into a
volumetric flask consisting of the appropriate matrix. The calibration
curve for peripheral blood was created in 50:50 pork blood:
deionized water, and the curve for vitreous fluid was made in blank
human vitreous humor. Both an external (UTAK TDM control 1)
and an internal (matrix spiked with drugs) quality control (QC)
samples were prepared and run with each batch of peripheral blood
samples. An internal QC was run with each vitreous humor batch.
Drug standards used to prepare the internal QC were purchased
from Cerilliant. The blank control consisted of drug-free pork blood
or drug-free vitreous fluid. The negative control was drug-free
matrix with 5-(p-methylphenyl)-5-phenylhydantoin (MPPH) added
as internal standard.
Sample preparation and analysis
Samples were analyzed via HPLC-DAD. Specimen samples were
added at a volume of 250 μL to Eppendorf microtubes. Then, 500 μL
of extraction solvent containing 16.7 mg/L MPPH as internal stan-
dard in acetonitrile was added to each tube. Samples were vortexed
and allowed to sit at room temperature for 10 minutes. All tubes
were centrifuged (10,000 × g maximum) for 10 minutes, and the
supernatant was transferred to autosampler vials and placed into the
autosampler.Calibrators,QCs, a negative control and a blank control
were prepared in the same manner.
HPLC-DAD analysis was based on a previously published method
(22). Briefly, an aliquot of 12 μL of sample was injected onto a
Zorbax Eclipse XDB-C18 column (2.1 × 150 mm, 5 μm particle
size with a guard column) on an 1100 series HPLC-DAD (Agilent
Technologies, Santa Clara, CA). A gradient elution was performed
using mobile phase A (15 mM phosphate buffer pH 2.9) and mobile
phase B (acetonitrile) at a flow rate of 0.45 mL per minute over a
30 minute run. Relative retention times to MPPH were calculated.
Compounds were identified and confirmed by their relative retention
time to the corresponding standard (±0.05) as well as a ultraviolet
(UV) spectra library match of ≥95%. A calibration curve (linear
regression) was generated using the relative peak areas of the calibra-
tors compared to that of the internal standard. A minimum of 3 non-
zero calibrators with a coefficient of determination (R2) ≥ 0.98 were
used. Calculations of unknown concentrations were performed using
this calibration curve. All calibrators and controls back-calculated
to within 20% of the target concentration. The lower limits of
quantification of the 7 drugs included in this study were as fol-
lows: acetaminophen, 2.0 mg/L; carbamazepine, 2.5 mg/L; ibuprofen,
2.0 mg/L; naproxen, 5 mg/L; phenobarbital, 5 mg/L; phenytoin,
5 mg/L; and salicylic acid, 20 mg/L.
Statistical analysis
Data were analyzed using GraphPad Prism version 7.03 (La Jolla,
CA,USA).Drug concentrations between vitreous fluid and peripheral
blood were analyzed using a paired two-tailed nonparametric t-test.
Significant difference was defined with a P < 0.05 and denoted with
∗∗ if P < 0.01 and with ∗∗∗∗ if P < 0.0001. Linear regressions were
used to generate the coefficients of determination for the X-Y scatter
plots.
Results
Prevalence of drug presence in peripheral blood and
vitreous solution
The concentrations of 7 different drugs were analyzed in peripheral
blood and vitreous fluid from 89 decedents over 2 years (Table I).
Cases originally tested for drugs routinely determined in peripheral
blood by this analytical method, and which had sufficient vitreous
fluid, were included in this investigation. Of those, acetaminophen
exhibited the highest frequency, being present in 50 of the 89 autopsy
cases (56%). In all of these cases, acetaminophen was also detected in
vitreous fluid. The next most abundant drug finding was naproxen,
found in 19% of cases, which was also detected in both peripheral
blood and vitreous fluid in all cases. Although ibuprofen and car-
bamazepine exhibited similar frequency in peripheral blood (10 and
Table I. Frequency of drug occurrence in peripheral blood and
vitreous humor in 89 autopsy cases
Drug Matrix Number of
findings
Frequency (%)
Acetaminophen Blood 50 56.2
Vitreous 50 56.2
Carbamazepine Blood 8 9.0
Vitreous 8 9.0
Ibuprofen Blood 9 10.1
Vitreous 4 4.5
Naproxen Blood 17 19.1
Vitreous 17 19.1
Phenobarbital Blood 4 4.5
Vitreous 4 4.5
Phenytoin Blood 3 3.4
Vitreous 2 2.2
Salicylic acid Blood 4 4.5
Vitreous 4 4.5
D
ow
nloaded from
 https://academ
ic.oup.com
/jat/advance-article-abstract/doi/10.1093/jat/bkz076/5613880 by U
niversity of C
alifornia, San D
iego Library user on 20 February 2020
Hubbard et al. 3
Figure 1. Mean concentrations of acidic drugs in peripheral blood and vitreous humor. Mean concentrations of (A) acetaminophen, (B) naproxen, (C) salicylic
acid, (D), ibuprofen, (E) carbamazepine, (F) phenobarbital and (G) phenytoin in peripheral blood and vitreous humor. Concentrations are in mg/L, and error bars
represent the standard error of the mean. Statistical significance was defined with a P < 0.05 and denoted with ∗∗ if P < 0.01 and with ∗∗∗∗ if P < 0.0001.
9%, respectively), carbamazepine was detected in vitreous fluid in
all 8 cases whereas ibuprofen was only detected in 4/9 (44%) cases.
Salicylic acid, phenobarbital and phenytoin were all detected in<5%
of autopsy cases. Only three cases had detectable levels of phenytoin
in peripheral blood and 2/3 had detectable levels in vitreous fluid.
The average concentrations of the seven acidic drugs were higher
in peripheral blood than in the vitreous fluid (Figure 1). Despite the
large intra-individual variation, this was statistically significant (non-
parametric t-test) for acetaminophen, carbamazepine, naproxen and
ibuprofen. Statistical significance was not reached for salicylic acid,
phenobarbital or phenytoin. This is likely due to the small sample
size (frequency of ≤4) and wide range of observed concentrations for
each of these drugs.
The average and range of concentrations of drugs in all cases with
detectable levels in peripheral blood are presented in Table II. For all
seven acidic compounds examined, the median V/PB ratio was less
than one, confirming that each drug exhibited higher concentrations
in peripheral blood than in the vitreous fluid. Concentrations of
acetaminophen in peripheral blood ranged from 5 to 170 mg/L with
a median concentration of 19.5 mg/L. The corresponding values
in vitreous fluid ranged from 1.1 to 96.0 mg/L. In the case with
an acetaminophen concentration of 170 mg/L, the corresponding
concentration in the vitreous fluid was 96 mg/L. The cause of death
for this particular case was amulti-drug intoxication.Acetaminophen
vitreous concentrations were 1–5-fold lower than concentrations in
peripheral blood in the majority of cases. In 3 of the 50 autopsy
cases with measurable levels of acetaminophen, the concentrations
were higher in vitreous fluid than in peripheral blood (peripheral
blood concentrations of 61, 12 and 16 mg/L and corresponding
vitreous fluid concentrations of 65, 15 and 25mg/L, respectively).No
obvious explanation for this can be gleaned from the causes of death
(accidental drug overdose, natural and suicide/jump, respectively) or
presence of other substances.
Ibuprofen exhibited the poorest ability to enter the vitreous
fluid, with less than half of the cases with measurable ibuprofen
in peripheral blood exhibiting detectable amounts in the vitreous.
Those with detectable concentrations exhibited a 4–14-fold reduction
in concentration in vitreous fluid compared to peripheral blood.
Phenytoin, ranging from 1.4 to 12 mg/L in peripheral blood, exhib-
ited a similar inability to enter into the vitreous fluid. Of the 3
cases where phenytoin was detected in peripheral blood, phenytoin
was undetectable in vitreous fluid of 1 case and exhibited a 6–8-
fold reduction compared to peripheral blood in the remaining 2
cases. Salicylic acid, phenobarbital, carbamazepine and naproxen all
demonstrated at least a 2-fold higher concentration in peripheral
blood than vitreous fluid in all cases except 1. Naproxen measured
at 8.1 mg/L in peripheral blood and 25 mg/L in vitreous fluid in 1
Table II. Average and range of drug concentrations in peripheral
blood and vitreous humor
Drug Matrix Mean Median Minimum Maximum
Acetaminophen Blood 34.4 19.5 5.0 170.0
Vitreous 19.2 14.5 1.1 96.0
V/PB ratio 0.6 0.6 0.1 1.5
Carbamazepine Blood 11.1 7.3 2.6 42.0
Vitreous 2.7 1.8 0.5 10.0
V/PB ratio 0.2 0.2 0.2 0.3
Ibuprofen Blood 12.0 11.0 3.8 23.0
Vitreous 0.9 0.0 0.0 5.4
V/B ratio 0.1 0.0 0.0 0.2
Naproxen Blood 11.7 9.3 5.1 22.0
Vitreous 1.1 0.8 0.3 3.5
V/PB ratio 0.1 0.1 0.0 0.3
Phenobarbital Blood 42.5 45.5 8.0 71.0
Vitreous 24.0 23.7 6.4 42.0
V/PB ratio 0.6 0.6 0.5 0.8
Phenytoin Blood 5.7 3.6 1.4 12.0
Vitreous 0.7 0.6 0.0 1.5
V/PB ratio 0.1 0.1 0.1 0.2
Salicylic acid Blood 63.0 55.0 12.0 130.0
Vitreous 16.8 16.0 2.3 33.0
V/PB ratio 0.3 0.3 0.2 0.5
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Figure 2. Correlations of drug concentrations between peripheral blood and vitreous humor. Scatter plots of peripheral blood (x-axis) and vitreous humor
(y-axis) concentrations (mg/L) of (A) acetaminophen, (B) naproxen, (C) salicylic acid, (D), ibuprofen, (E) carbamazepine, (F) phenobarbital and (G) phenytoin.
Linear regression equations and the coefficient of determination (R2) for the line of best fit are written within each graph.
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autopsy case. All other cases had a 5–85-fold higher concentration
of naproxen in peripheral blood as compared with vitreous fluid.
The median value for naproxen in vitreous fluid was 0.8 mg/L. The
vitreous fluid specimen with a measured concentration of 25 mg/L
was greater than 3 standard deviations from the mean and a Dixon’s
Q test with >99% confidence interval determined this to be an
outlier. Therefore, this specimen was removed from all analyses and
is not presented in any of the figures.
Correlations between matrices
The linear agreement between peripheral blood and vitreous fluid
is shown in Figure 2. The best correlation observed was for carba-
mazepine, with a coefficient of determination (R2) of 0.995. The next
best correlations were seen with phenobarbital and phenytoin, both
exhibiting an R2 value >0.95. This suggests that vitreous fluid can
be used to estimate peripheral blood concentrations when necessary
for these acidic AEDs. However, caution should be taken when
interpreting these results due to the low sample size (n ≤ 4) of both
phenobarbital and phenytoin.Of the OTC analgesics, acetaminophen
exhibited the best correlation with an R2 of 0.718, whereas naproxen
exhibited the worst correlation with an R2 of 0.322. Therefore,
acidic OTC analgesic concentrations do not correlate well between
peripheral blood and vitreous fluid.
Discussion
Overall, we observed decreased concentrations of acidic drugs in vit-
reous fluid compared to peripheral blood resulting in lowV/PB ratios.
Ibuprofen exhibited the lowest detection rate and concentration in
the vitreous humor. Acetaminophen was detected in more than half
the autopsy cases presented. This is logical because acetaminophen
is widely used as an analgesic and antipyretic, is occasionally used
to commit suicide and is coformulated with opioids, which have
high addiction and overdose potential (23). Vitreous humor showed
potential as an alternative matrix for detection of all drugs included in
this study with the exception of ibuprofen and phenytoin. Ibuprofen
and phenytoin exhibited low concentrations in the vitreous humor
and was detected in 4/9 and 2/3 cases where it was measurable
in peripheral blood, respectively. Finally, a good linear correlation
between vitreous humor and peripheral blood for the AEDs suggest
a potential mechanism to predict peripheral blood concentrations
when this matrix is unavailable.
Size, rate of clearance, volume of distribution, half-life, acidity
(pKa) and lipophilicity (partition coefficient, logP) all may affect
the ability of a drug to cross the blood–retinal barrier (Table III)
(24, 25). In general, the OTC analgesics tend to be absorbed rapidly
and reach peak concentrations shortly thereafter; the peak concen-
tration of acetaminophen, ibuprofen and salicylic acid are all within
1 hour, whereas naproxen peaks within 2–4 hours (25). AEDs, on the
other hand, tend to exhibit slow absorption, have limited aqueous
solubility, distribute rapidly and display more variable pharmacoki-
netics (25). Carbamazepine is absorbed erratically and is rapidly
distributed into all tissues. The concentrations of carbamazepine in
cerebrospinal fluid correlate well with free drug levels in plasma,
indicating it is capable of crossing these biological barriers. Phenytoin
does not exhibit linear kinetics, and the rate of elimination depends
on the concentration. These delayed pharmacokinetic properties may
contribute to their ability to better equilibrate between the blood and
vitreous humor (26).
In a previous study, we demonstrated that many drugs were
similar in concentration or trended toward higher concentrations in
vitreous fluid compared to peripheral blood (21). These included
opioids such as oxycodone and hydrocodone. These alkaloid drugs
are largely neutral and are highly lipid soluble and known to pen-
etrate the blood–brain barrier (27), which may contribute to their
ability to cross the blood–retinal barrier. Antidepressants such as
trazodone, sertraline and venlafaxine, as well as diazepam, a benzo-
diazepine, exhibit lower concentrations in vitreous humor compared
to peripheral blood (21, 28). Relative to opioids, these drugs exhibit
a slightly higher polarity, which may contribute to their inability to
penetrate the blood–retinal barrier. Similarly, the acidic drugs in this
study all exhibited low V/PB ratios, indicating chemical properties
that reduce its ability to enter the vitreous humor. Acetaminophen
exhibited a relatively high detection rate in the vitreous humor
compared to ibuprofen and is minimally protein bound (<20%) (25).
Ibuprofen exhibited a poor detection rate in vitreous humor and is
almost entirely protein bound (>99%) (25). The V/PB ratio is likely
influenced by both lipophilicity and protein binding (29). Finally,
PMR is greatest with lipid-soluble drugs, whereas neutral and acidic
drugs are less affected (2). Therefore, lower concentrations of acidic
drugs may be due to—or a reflection of—reduced redistribution.
When blood is not available for postmortem analysis, a tox-
icologist may have to rely on vitreous humor for drug screens.
However, interpretation is difficult without established reference
ranges or correlative data to blood concentrations. Bevalot and
Table III. Drug pharmacokinetic characteristics
Drug Molecular
weight
(g/mol)
Bound in
plasma
(%)
Clearance (mL/min/kg) Volume of
distribution
(L/kg)
Half-life
(hours)
pKa LogP
Acetaminophen 151 <20 5± 1.4 0.95± 0.12 2± 1.4 9.759 0.55
Carbamazepine 236 74± 3 1.3± 0.5 1.4± 0.4 15± 5 N/A 2.93
Ibuprofen 206 >99 0.75± 0.20 0.15± 0.02 2± 0.5 4.366 3.75
Naproxen 230 99.7± 0.1 0.13± 0.02 0.16± 0.02 14± 1 4.234 2.97
Phenobarbital 232 51± 3 0.062± 0.013 0.54± 0.03 99± 18 N/A 1.52
Phenytoin 252 89± 23 Nonlinear,
Vmax = 5.9± 1.2 mg/kg/day;
Km = 5.7± 2.9 mg/L
0.64± 0.04 6–24 N/A 2.14
Salicylic acid 131 80–90 N/A 0.17 2–30 13.038, 2.983 1.2
Pharmacokinetic properties were obtained from Hardman and Limbird (2001) and physical constants from ChemDraw (1985) (24, 25).
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colleagues (2011) showed that meprobamate, a carbamate derivative,
exhibits a linear relationship between peripheral blood and vitreous
humor concentrations using a logarithmic model with an R2 of
0.94 (12). Here, we found that carbamazepine, a much more com-
monly prescribed drug, also exhibits a linear relationship between
vitreous humor and peripheral blood and can serve as a means to
estimate blood concentrations when necessary. However, a direct
correlation between OTC analgesic vitreous humor and peripheral
blood concentrations was not observed. Therefore, vitreous humor
concentrations of these drugs may be used as an alternative matrix
for detection of acetaminophen, naproxen and salicylic acid, but not
to necessarily appropriate to estimate blood concentrations. The low
detection rate of ibuprofen in vitreous humor limits its potential
as both an alternative matrix and a means to correlate to blood
concentrations.
AEDs often have a narrow therapeutic index and are frequently
measured to optimize dosing. Phenytoin has a therapeutic index
of 10–20 mg/L (30) and is considered toxic when concentrations
exceed 30 mg/L. None of the cases presented here exceeded 12 mg/L
in peripheral blood. Carbamazepine has a therapeutic range of 4–
12 mg/L and exhibits adverse central nervous system (CNS) effects
at concentrations >12 mg/L (30). Here, the median observed blood
concentration of carbamazepine was 7.3 mg/L, and only 1 case had
carbamazepine peripheral blood concentrations above the therapeu-
tic range. The therapeutic range of phenobarbital is 15–40 mg/L
and has toxic effects at concentrations >40 mg/L (30). Of the 4
cases with detectable levels of phenobarbital included in this study, 2
decedents had concentrations above 40 mg/L in peripheral blood (70
and 71mg/L),whereas the other 2 fell within or below the therapeutic
range (8 and 21 mg/L). In all cases, concentration of AEDs in vitreous
humor was lower in peripheral blood but correlated well (R2 > 0.95).
This highlights the importance of monitoring AEDs and emphasizes
the significance of vitreous humor as an alternative matrix when
necessary.
Limitations
First, the vitreous assay was based on analytical method development
for measuring drugs in blood, and an extensive validation was not
performed. Calibrators and QCs were spiked into blank vitreous
humor. A linear calibration curve was established, and QCs with
acceptable concentrations (within 20% of the target) and similar
responses (area counts) as the blood QCs were demonstrated. The
extraction efficiency and appropriate detection limits were not inves-
tigated. Second, some compounds, particularly phenytoin, suffered
from a low number of case specimens due to its low prevalence
in autopsy cases. Third, antemortem values were not available to
establish the extent of PMR in either matrix.
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